Toggle navigation
About
Approach
Team
Companies
News Room
Contact
Medicxi Announces $40m investment in D3 Bio
Press Release
Medicxi and Starpharma create Petalion Therapeutics to develop novel dendrimer-based treatments
Press Release
Alys Pharmaceuticals launches with $100M financing from Medicxi to advance Immuno-Dermatology focused pipeline
Press Release